2005 Annual Meeting | Attention-Deficit Hyperactivity Disorder Across the Lifespan: A Primer for the Neurologist
| 06:45 AM - 07:15 AM |
ADHD: Clinical Features and Comorbidities Across the Lifespan
Max Wiznitzer, MD, FÂé¶¹´«Ã½Ó³» |
|
| 06:45 AM - 08:30 AM |
Breakfast
|
|
| 07:15 AM - 07:45 AM |
ADHD Treatment Options: Medication
Max Wiznitzer, MD, FÂé¶¹´«Ã½Ó³» |
|
| 07:45 AM - 08:15 AM |
ADHD Treatment Options: Âé¶¹´«Ã½Ó³»al, Behavioral, and Occupational
Martha B. Denckla, MD |
|
| 08:15 AM - 08:30 AM |
Questions and Answers
|
| Max Wiznitzer, MD, FÂé¶¹´«Ã½Ó³» | Dr. Wiznitzer has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Department of Health and Human Services - Vaccine Injury Compensation Program. Dr. Wiznitzer has a non-compensated relationship as a Board of Directors with CHADD that is relevant to Âé¶¹´«Ã½Ó³» interests or activities. Dr. Wiznitzer has a non-compensated relationship as a Committee Member with American Board of Psychiatry and Neurology that is relevant to Âé¶¹´«Ã½Ó³» interests or activities. |
| Martha B. Denckla, MD | No disclosure on file |